COLON TARGETED DELIVERY AND STABILIZATION OF MONOCLONAL ANTIBODIES FOR LOCAL TREATMENT OF INFLAMMATORY BOWEL DISEASES

被引:0
|
作者
Yadav, Vipul
Matiz, Silvia
Thomaidou, Stavrina
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S5 / S5
页数:1
相关论文
共 50 条
  • [21] Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer
    Kumar, Ankaj
    Vaiphei, Klaudi K.
    Singh, Naveen
    Chigurupati, Sri Pada Datta
    Paliwal, Shivani Rai
    Paliwal, Rishi
    Gulbake, Arvind
    NANOMEDICINE, 2024, 19 (15) : 1347 - 1368
  • [22] Monoclonal antibodies in immune and inflammatory diseases
    Andreakos, E
    Taylor, PC
    Feldmann, M
    CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (06) : 615 - 620
  • [23] A CRITICAL REVIEW ON COLON TARGETED DRUG DELIVERY SYSTEMS FOR MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
    Jaiswal, Meenakshi
    Lanjhiyana, S. K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (03): : 985 - 992
  • [24] Anticardiolipin antibodies in inflammatory bowel diseases
    Perri, F
    Villani, MR
    Annese, V
    Latiano, A
    Napolitano, G
    Caruso, N
    Quitadamo, M
    Lombardi, G
    Caradonna, G
    Andriulli, A
    GASTROENTEROLOGY, 1996, 110 (04) : A989 - A989
  • [25] Guar gum-based colon-specific drug delivery systems for the treatment of Inflammatory Bowel Diseases
    Yellela, S.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S56 - S56
  • [26] (Auto)antibodies in inflammatory bowel diseases
    Vermeire, Severine
    Vermeulen, Nathalie
    Van Assche, Gert
    Bossuyt, Xavier
    Rutgeerts, Paul
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2008, 37 (02) : 429 - +
  • [27] Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease
    Lamprecht, A
    Ubrich, N
    Yamamoto, H
    Schäfer, U
    Takeuchi, H
    Maincent, P
    Kawashima, Y
    Lehr, CM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (02): : 775 - 781
  • [28] Monoclonal antibodies target inflammatory bowel disease
    Hampton, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (01): : 29 - 30
  • [29] Applications of monoclonal antibodies and biotechnology products in the treatment of chronic inflammatory diseases
    de la Fuente, JLM
    REVISTA CLINICA ESPANOLA, 2005, 205 (03): : 127 - 136
  • [30] Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review
    Cui, Mingxiao
    Zhang, Min
    Liu, Kehai
    CARBOHYDRATE POLYMERS, 2021, 272